ClinicalTrials.gov
ClinicalTrials.gov Menu

Using Values to Enhance Inmates' Response to Substance Use and HIV Risk Feedback

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT03501732
Recruitment Status : Not yet recruiting
First Posted : April 18, 2018
Last Update Posted : April 18, 2018
Sponsor:
Collaborators:
OAR, Fairfax
Slonky, Inc
Information provided by (Responsible Party):
June Tangney, George Mason University

Brief Summary:

A key component of effective offender treatment is an initial assessment of risk factors followed by feedback to facilitate problem awareness and engagement in appropriate treatment and/or behavior change. Feedback regarding areas of high risk, however, can be experienced as threatening.

The investigators propose to develop, fine-tune, and pilot-test a computerized system for risk assessment and feedback, including evaluation of a brief pre-feedback prosocial values affirmation exercise (Cohen & Sherman, 2014) aimed at decreasing defensiveness and increasing inmates' willingness to access and process risk-relevant information and to utilize post-release treatment resources, thereby reducing post-release substance misuse, HIV risk behavior, and criminal recidivism. Participants will be 170 jail inmates nearing release into the community - 20 pilot participants and 150 study participants randomly assigned to one of three conditions: (1) Values Affirmation + Personalized Risk Feedback; (2) Personalized Risk Feedback only; (3) Control. The baseline and risk assessment, values affirmation manipulation, and personalized risk feedback will be presented via touch-screen computers, requiring minimal training to administer. Analyses will assess:

  1. The feasibility of utilizing a computerized system to assess and share risk information with jail inmates, including a brief values affirmation exercise to reduce defensiveness;
  2. The acceptability of this approach from the perspectives of jail staff and inmates themselves;
  3. The impact of the intervention on observed proximal outcomes (mechanisms of action), such as time spent viewing feedback, electing to print a copy of informational and treatment resources, and consequent changes in perceptions of risk, treatability, etc.;
  4. The impact of the intervention on key post-release outcomes including engagement in relevant treatment services, substance misuse, HIV risk behaviors, re-offense and re-arrest;
  5. The links between proximal outcomes (MOAs) and key post-release outcomes;
  6. Potential moderators of treatment effectiveness.

Condition or disease Intervention/treatment Phase
Substance Use HIV Risk Behavior Behavioral: Values Affirmation Behavioral: Risk Feedback Not Applicable

Study Type : Interventional  (Clinical Trial)
Estimated Enrollment : 150 participants
Allocation: Randomized
Intervention Model: Factorial Assignment
Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)
Primary Purpose: Treatment
Official Title: Using Values to Enhance Inmates' Response to Substance Use and HIV Risk Feedback
Estimated Study Start Date : June 1, 2018
Estimated Primary Completion Date : July 15, 2019
Estimated Study Completion Date : July 15, 2019

Resource links provided by the National Library of Medicine

MedlinePlus related topics: HIV/AIDS

Arm Intervention/treatment
Experimental: Values Affirmation plus Risk Feedback
Values Affirmation with Risk Feedback in substance use and HIV domains of risk
Behavioral: Values Affirmation
Experimental Group selects two values and describes why they are important

Behavioral: Risk Feedback
Experimental and comparator conditions both receive normative feedback in domains of risk

Active Comparator: Risk Feedback
Sham Values Affirmation with Risk Feedback in substance use and HIV domains of risk
Behavioral: Risk Feedback
Experimental and comparator conditions both receive normative feedback in domains of risk

No Intervention: Sleep Control
Description of sleep habits in lieu of values affirmation/sham values affirmation. No risk feedback



Primary Outcome Measures :
  1. Changes in substance use [ Time Frame: 3 months post-release (Time 2) ]
    Changes in substance use -- among those who were identified at risk and who thus received feedback, pre-post incarceration changes in terms of pre-incarceration standard deviations. If more than one domain of feedback, average standard deviation change.

  2. Changes in HIV risk behavior [ Time Frame: 3 months post-release (Time 2) ]
    Changes in HIV risk behavior -- among those who were identified at risk and who thus received feedback, pre-post incarceration changes in terms of pre-incarceration standard deviations. If more than one domain of feedback (risky sex, risky needle use), average standard deviation change.


Secondary Outcome Measures :
  1. Changes in accuracy of perceptions of normative risk behavior [ Time Frame: Immediately following intervention (Time 1) ]
    Changes in accuracy of perceptions of normative behavior (pre-post intervention changes in terms of pre-intervention standard deviations) in areas of risk/feedback

  2. Requests Community Resources [ Time Frame: Immediately following intervention (Time 1) ]
    Choose to print a copy of community resources in domain(s) of risk

  3. Makes Use of Community Resources [ Time Frame: 3 months post-release (Time 2) ]
    Makes use of relevant community services during 3 months post-release



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years and older   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Sufficient proficiency in spoken English to understand computer-assisted assessments and feedback
  • post-sentencing with a sentence (i.e., less than 12 months) likely to be served out at the jail (vs. a state or federal prison) and likely to be released into the community. The invitation to participate will be timed so treatment is delivered toward the end of incarceration (within one week of release) to minimize decay of effects, and to capitalize on the motivational value of the up-coming release.

Exclusion Criteria:

  • Those with detainers to other jurisdictions and to Immigration and Customs Enforcement (ICE)

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03501732


Contacts
Contact: June P Tangney, PhD 7039931365 jtangney@gmu.edu
Contact: Jeffrey Stuewig, PhD 7039931365 jstuewig@gmu.edu

Sponsors and Collaborators
George Mason University
OAR, Fairfax
Slonky, Inc
Investigators
Principal Investigator: June P Tangney, PhD George Mason University

Responsible Party: June Tangney, Professor, George Mason University
ClinicalTrials.gov Identifier: NCT03501732     History of Changes
Other Study ID Numbers: R34DA042974-01 ( U.S. NIH Grant/Contract )
First Posted: April 18, 2018    Key Record Dates
Last Update Posted: April 18, 2018
Last Verified: April 2018
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: Yes
Plan Description: We will make the data and associated documentation available to researchers under a data-sharing agreement that provides for: (1) release of individually prepared datasets containing the subset of variables required to answer the requester's research question(s); (2) a commitment to using the data only for research purposes and not to attempt to identify any individual participant; (3) a commitment to securing the data using appropriate computer technology housed in a secure laboratory facility; and (4) a commitment to destroying or returning the data after analyses are completed. Because of the exceptionally sensitive nature of the data, detailed criminal history and re-arrest information and self-reports of undetected criminal behavior will not be shared. Data requests will be accepted beginning 12 months after publication of the primary findings of the proposed project.
Supporting Materials: Study Protocol
Statistical Analysis Plan (SAP)
Informed Consent Form (ICF)
Clinical Study Report (CSR)
Analytic Code
Time Frame: Beginning 12 months after publication of the primary findings of the proposed project, for 5 years.
Access Criteria: Researchers who commit to using the data only for research purposes and not to attempt to identify any individual participant; who commit to securing the data using appropriate computer technology housed in a secure laboratory facility; and who commit to destroying or returning the data after analyses are completed.

Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No